Publication | Closed Access

Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

Receptor-interacting ProteinLymphoid NeoplasiaHematological MalignancyAutoimmune DiseaseMedicineImmunologyPathologyAutoimmunityLymphotoxin AlfaGene PolymorphismsOncologyImmune-related Gene PolymorphismCancer Research